Pradžia › 1 tipo cukrinis diabetas › Pennsylvania
1 tipo cukrinis diabetas klinikiniai tyrimai Pennsylvania
13 tyrimai dėl 1 tipo cukrinis diabetas ieško dalyvių vietose Pennsylvania.
Miestai Pennsylvania
Oficialus tyrimo tekstas (anglų kalba)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
Renkami dalyviai3 fazė
Amžius nuo 1 iki 35 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
Renkami dalyviai3 fazė
Amžius nuo 1 iki 35 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
Renkami dalyviai3 fazė
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
Renkami dalyviai2 fazė
Amžius nuo 4 iki 34 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
Renkami dalyviai2 fazė
Amžius nuo 8 iki 45 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
Renkami dalyviai1/2 fazė
Amžius nuo 9 iki 20 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Renkami dalyviai2 fazė
Amžius nuo 5 iki 40 · Visoms lytims · Atnaujinta 2026-08-24 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
Renkami dalyviai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-16 · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-04-13 · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-03-23 · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-03 · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 2 iki 45 · Visoms lytims · Atnaujinta 2025-07-01 · NCT00097292Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.